Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2023-05-31 | OssDsign | Årsstämma har hållits i OssDsign AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-31 | OssDsign | Annual General Meeting held in OssDsign AB | Pressreleaser | Ladda ner | Visa Stäng |
Pressreleaser |
Annual General Meeting held in OssDsign ABThe annual general meeting resolved: – to adopt the profit and loss statement and the balance sheet and the group profit and loss statement and the group balance sheet for the financial year 2022; – that the company’s result shall be carried forward in new account and that no dividend shall be paid; – to grant the board members and the CEO discharge from liability for the financial year 2022; – that the board of directors shall consist of six ordinary members without deputy members, to re-elect Simon Cartmell, Anders Qvarnström, Håkan Engqvist, Newton Aguiar, Viktor Drvota and Jill Shiaparelli as ordinary board members, and to re-elect Simon Cartmell as chairman of the board; – that a registered accounting firm shall be elected as auditor and to re-elect Ernst & Young AB as the company’s auditor; – that fees payable to the board members until the end of the next annual general meeting shall amount to a total of SEK 1,250,000 out of which SEK 350,000 shall be paid to the chairman, SEK 250,000 to each of Anders Qvarnström, Newton Aguiar and Jill Schiaparelli, and SEK 150,000 to Håkan Engqvist; – that fees payable to the auditor is to be paid in accordance with approved invoices; – on an authorization for the board of directors to increase the share capital through issuance of new shares, warrants and/or convertible debentures through which the company’s share capital may be increased by an amount corresponding to not more than 20 per cent of the share capital after such issue(s); and – to change the limits in the articles of association with respect to share capital and number of shares whereby the company’s share capital shall be not less than SEK than SEK 4,375,000 and not more than SEK 17,500,000 and the number of shares in the company shall be no less than 70,000,000 and no more than 280,000,000. For further information, please contact: About OssDsign |
||||
2023-05-24 | Penser Access | Penser Access: Exponentiell tillväxt för Catalyst - OssDsign | Pressreleaser | Visa Stäng |
|
||||
2023-05-24 | Redeye | Redeye: OssDsign Q1 - Steep acceleration of sales | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-23 | OssDsign | OssDsign AB (publ) publishes Q1 2023 Interim Report | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-05-23 | OssDsign | OssDsign AB (publ) publicerar delårsrapport för första kvartalet 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-05-09 | OssDsign | OssDsign AB: 1 000 patienter behandlade med OssDsign® Catalyst i USA | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-09 | OssDsign | OssDsign AB: 1,000 patients treated with OssDsign® Catalyst in the U.S. | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-27 | OssDsign | OssDsign AB: OssDsign publishes Annual Report 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-27 | OssDsign | OssDsign AB: OssDsign publicerar Årsredovisning 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-27 | OssDsign | OssDsign AB: KALLELSE TILL ÅRSSTÄMMA I OSSDSIGN AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-27 | OssDsign | OssDsign AB: NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN OSSDSIGN AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-27 | OssDsign | OssDsign AB: OssDsign når kommersiell milstolpe med 750 implantat sålda i Tyskland | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-27 | OssDsign | OssDsign AB: OssDsign reaches commercial milestone of 750 implants sold in Germany | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-20 | OssDsign | OssDsign AB: OssDsign increases operational efficiency and reduces Cranial PSI lead time by up to 40 percent | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-20 | OssDsign | OssDsign AB: OssDsign effektiviserar sin tillverkning och minskar ledtiden för Cranial PSI med upp till 40 procent | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-14 | OssDsign | OssDsign AB: OssDsign når kommersiell milstolpe - 200 sålda implantat i Frankrike | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-14 | OssDsign | OssDsign AB: OssDsign reaches commercial milestone of 200 implants in France | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-22 | Penser Access | Penser Access: Inne i kraftfull tillväxtfas - OssDsign | Pressreleaser | Visa Stäng |
|
||||
2023-02-22 | Redeye | Redeye: OssDsign Q4 - Delivering well in tough conditions | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-21 | OssDsign | OssDsign AB (publ) publishes Year-end Report 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-21 | OssDsign | OssDsign AB (publ) publicerar bokslutskommuniké 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-01-10 | OssDsign | OssDsign AB: OssDsign Catalyst 1cc är nu lanserad och fullt tillgänglig på den amerikanska marknaden | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-01-09 | OssDsign | OssDsign AB: OssDsign når milstolpe - 500 patienter behandlade med OssDsign® Catalyst i USA | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-01-04 | OssDsign | OssDsign AB: Den första patientrapporten med OssDsign Catalyst visar fullständig ryggradsfusion sex månader efter steloperation | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-12-16 | OssDsign | OssDsign AB: Långtidsuppföljning fortsätter visa låga komplikationsnivåer vid behandling med OssDsign Cranial PSI | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-29 | OssDsign | OssDsign AB completes a directed new share issue raising proceeds of approximately SEK 65.6 million | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-29 | OssDsign | OssDsign AB genomför en riktad nyemission av aktier och tillförs därigenom cirka 65,6 miljoner kronor | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-29 | OssDsign | OssDsign AB avser att genomföra en riktad nyemission av aktier | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-29 | OssDsign | OssDsign AB intends to carry out a directed new share issue | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-29 | Penser Access | Penser Access: Interview with OssDsign - Erik Penser Bank - 28 november 2022 | Analyser | Visa Stäng |
|
||||
2022-11-23 | Penser Access | Penser Access: Ytterligare ett försäljningsmässigt starkt kvartal - OssDsign | Analyser | Visa Stäng |
|
||||
2022-11-23 | Redeye | Redeye: OssDsign Q3 - Catalyst positively surprises, but still a difficult climate | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-22 | OssDsign | OssDsign AB (publ) publicerar delårsrapport för tredje kvartalet 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-22 | OssDsign | OssDsign AB (publ) publishes Q3 2022 Interim Report | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-17 | OssDsign | OssDsign AB: De första resultaten från en långtidsuppföljning av OssDsign Catalyst visar noll procent produktrelaterade komplikationer | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-09 | OssDsign | OssDsign AB: OssDsign når milstolpen 100 patienter i sitt PROPEL-register tidigare än väntat | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-03 | OssDsign | OssDsign AB: OssDsign utökar Catalyst-portföljen och lanserar en ny produkt anpassad för fler typer av kirurgiska ingrepp | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-09-29 | OssDsign | OssDsign AB: BioStock Investor Meeting: Interview with OssDsign | Pressreleaser | Visa Stäng |
|
||||
2022-09-29 | OssDsign | OssDsign AB: BioStock Investor Meeting: Intervju med OssDsign | Pressreleaser | Visa Stäng |
|
||||
2022-09-26 | OssDsign | OssDsign AB: Ny vetenskaplig publikation av den hittills största fallstudien av OssDsign Cranial PSI i USA visar positiva behandlingsresultat samt total avsaknad av implantatrelaterade komplikationer | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-09-22 | OssDsign | OssDsign AB: BioStock Investor Meeting: OssDsign presents | Pressreleaser | Visa Stäng |
|
||||
2022-09-22 | OssDsign | OssDsign AB: BioStock Investor Meeting: OssDsign presenterar | Pressreleaser | Visa Stäng |
|
||||
2022-09-13 | Penser Access | Penser Access: Interview with OssDsign - Erik Penser Bank - September 12th 2022 | Analyser | Visa Stäng |
|
||||
2022-08-24 | Penser Access | Penser Access: USA-marknaden driver kraftig försäljningsökning - OssDsign | Analyser | Visa Stäng |
|
||||
2022-08-24 | Redeye | Redeye: OssDsign - A taste of a better market outlook | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-08-23 | OssDsign | OssDsign AB (publ) publicerar delårsrapport för andra kvartalet 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-08-23 | OssDsign | OssDsign AB (publ) publishes Q2 2022 Interim Report | Pressreleaser | Ladda ner | Visa Stäng |
|